Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

about

Characterization of the Differential Adverse Event Rates by Race/Ethnicity Groups for HPV Vaccine by Integrating Data From Different Sources.Immunology beliefs as a factor in vaccine opposition among complementary and alternative medical providers

P2860

Q55007708-8EA052C7-679F-4D09-8A50-8F3E2C6DE233 Q59136691-B1C2FB3C-7FA3-4A1F-A00C-102D276FCB54

P2860

Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

Item

http://www.wikidata.org/entity/Q48168601

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Human papillomavirus vaccinati ...... une and neurological diseases.

@en

Human papillomavirus vaccinati ...... une and neurological diseases.

@nl

type

Item

label

Human papillomavirus vaccinati ...... une and neurological diseases.

@en

Human papillomavirus vaccinati ...... une and neurological diseases.

@nl

prefLabel

Human papillomavirus vaccinati ...... une and neurological diseases.

@en

Human papillomavirus vaccinati ...... une and neurological diseases.

@nl

P1476

Human papillomavirus vaccinati ...... mune and neurological diseases

@en

P2093

L Arnheim-Dahlström

http://www.w3.org/2001/XMLSchema#string

N M Scheller

http://www.w3.org/2001/XMLSchema#string

O Grönlund

http://www.w3.org/2001/XMLSchema#string

P2860

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

Safety of human papillomavirus vaccines: a review

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Safety of human papillomavirus vaccines: a review.

Tutorial in biostatistics: the self-controlled case series method.

External review and validation of the Swedish national inpatient register.

Addressing the vaccine confidence gap.

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

Screening for celiac disease in Danish adults

Autoimmune diseases after adolescent or adult immunization: what should we expect?

P304

154-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIM.12694

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

Anders Hviid

Björn Pasternak

Henrik Svanström

P577

2017-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29044769

http://www.w3.org/2001/XMLSchema#string

Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

about

P2860

P2860

Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698